組織
American patients of minority groups
影響を受けたインシデント
インシデント 1723 レポート
NarxCare’s Risk Score Model Allegedly Lacked Validation and Trained on Data with High Risk of Bias
2020-07-01
NarxCare's overdose risk algorithm, lacking peer-reviewed validation, uses sensitive data like doctor visits, prescriptions, and possibly genetic information, leading to significant biases against women and Black patients. Factors like sexual abuse and criminal records exacerbate stigmas and disparities, often resulting in unjust denial of necessary pain medication. The newly approved AvertD genetic test shares similar issues, further complicating and potentially harming medical treatment decisions.
もっと